{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:06:17Z","timestamp":1790816777756,"version":"4.1.0"},"reference-count":105,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fibrosis can be defined as a pathological process in which deposition of connective tissue replaces normal parenchyma. The kidney, like any organ or tissue, can be impacted by this maladaptive reaction, resulting in persistent inflammation or long-lasting injury. While glomerular injury has traditionally been regarded as the primary focus for classification and prognosis of lupus nephritis (LN), increasing attention has been placed on interstitial fibrosis and tubular atrophy as markers of injury severity, predictors of therapeutic response, and prognostic factors of renal outcome in recent years. This review will discuss the fibrogenesis in LN and known mechanisms of renal fibrosis. The importance of the chronicity index, which was recently added to the histological categorization of LN, and its role in predicting treatment response and renal prognosis for patients with LN, will be explored. A better understanding of cellular and molecular pathways involved in fibrosis in LN could enable the identification of individuals at higher risk of progression to chronic kidney disease and end-stage renal disease, and the development of new therapeutic strategies for lupus patients.<\/jats:p>","DOI":"10.3390\/ijms232214317","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T06:11:34Z","timestamp":1668751894000},"page":"14317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Renal Fibrosis in Lupus Nephritis"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9441","authenticated-orcid":false,"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Cozzi","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Barinotti","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-2606","authenticated-orcid":false,"given":"Massimo","family":"Radin","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cecchi","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8019-5749","authenticated-orcid":false,"given":"Roberta","family":"Fenoglio","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-6047","authenticated-orcid":false,"given":"Daniele","family":"Mancardi","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Wilson Jones","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rossi","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4419-6813","authenticated-orcid":false,"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[{"name":"University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit, Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), Department of Clinical and Biological Sciences, San Giovanni Bosco Hub Hospital, University of Turin, 10154 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and Unique Mechanisms Regulate Fibrosis in Various Fibroproliferative Diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1513\/pats.200601-012TK","article-title":"Matrix Metalloproteases in Aberrant Fibrotic Tissue Remodeling","volume":"3","author":"Pardo","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Distler, J.H.W., Gy\u00f6rfi, A.H., Ramanujam, M., Whitfield, M.L., K\u00f6nigshoff, M., and Lafyatis, R. Shared and Distinct Mechanisms of Fibrosis. Nat. Rev. Rheumatol., 2019.","DOI":"10.1038\/s41584-019-0322-7"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and Molecular Mechanisms of Fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal Fibrosis: New Insights into the Pathogenesis and Therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014A Common Pathway to Organ Injury and Failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic Kidney Disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/ajt.13180","article-title":"Renal Allograft Fibrosis: Biology and Therapeutic Targets","volume":"15","author":"Boor","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41584-020-0401-9","article-title":"Protecting the Kidney in Systemic Lupus Erythematosus: From Diagnosis to Therapy","volume":"16","author":"Maria","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus Nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society Classification for Lupus Nephritis: Clarification of Definitions, and Modified National Institutes of Health Activity and Chronicity Indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","article-title":"Mechanisms of Pulmonary Fibrosis","volume":"55","author":"Thannickal","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and Function of Myofibroblasts in Kidney Fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse Origins of the Myofibroblast\u2014Implications for Kidney Fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/nm.3282","article-title":"Targeting of Av Integrin Identifies a Core Molecular Pathway That Regulates Fibrosis in Several Organs","volume":"19","author":"Henderson","year":"2013","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","article-title":"Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention","volume":"15","author":"Liu","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","article-title":"WNT-\u03b2-Catenin Signalling\u2014A Versatile Player in Kidney Injury and Repair","volume":"17","author":"Schunk","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"830340","DOI":"10.3389\/fphar.2021.830340","article-title":"Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt\/\u03b2-Catenin Signaling","volume":"12","author":"Hu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: Versatile Players in Renal Inflammation and Fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/kisup.2014.7","article-title":"Macrophages Promote Renal Fibrosis through Direct and Indirect Mechanisms","volume":"4","author":"Wang","year":"2014","journal-title":"Kidney Int. Suppl."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kim, M.-G., Kim, S.C., Ko, Y.S., Lee, H.Y., Jo, S.-K., and Cho, W. (2015). The Role of M2 Macrophages in the Progression of Chronic Kidney Disease Following Acute Kidney Injury. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143961"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1797.2010.01439.x","article-title":"Alteration in the Phenotype of Macrophages in the Repair of Renal Interstitial Fibrosis in Mice","volume":"16","author":"Kushiyama","year":"2011","journal-title":"Nephrology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.kint.2019.11.025","article-title":"Kidney Residency of VISTA-Positive Macrophages Accelerates Repair from Ischemic Injury","volume":"97","author":"Park","year":"2020","journal-title":"Kidney Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI151189","article-title":"Kidney VISTA Prevents IFN-\u03b3\/IL-9 Axis\u2013Mediated Tubulointerstitial Fibrosis after Acute Glomerular Injury","volume":"132","author":"Kim","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/cei.13415","article-title":"VISTA: Coming of Age as a Multi-Lineage Immune Checkpoint","volume":"200","author":"ElTanbouly","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.40020","article-title":"VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis","volume":"69","author":"Ceeraz","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14846","DOI":"10.1073\/pnas.1407447111","article-title":"Disruption of the Immune-Checkpoint VISTA Gene Imparts a Proinflammatory Phenotype with Predisposition to the Development of Autoimmunity","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: The Master Regulator of Fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajpath.2012.09.009","article-title":"Transforming Growth Factor \u03b2-1 Stimulates Profibrotic Epithelial Signaling to Activate Pericyte-Myofibroblast Transition in Obstructive Kidney Fibrosis","volume":"182","author":"Wu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"684236","DOI":"10.3389\/fphys.2021.684236","article-title":"Transforming Growth Factor-\u03b2 and Long Non-Coding RNA in Renal Inflammation and Fibrosis","volume":"12","author":"Gu","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ki.1996.65","article-title":"Expression of Transforming Growth Factor-Beta Isoforms in Human Glomerular Diseases","volume":"49","author":"Yamamoto","year":"1996","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ki.1997.50","article-title":"Oxygen and Renal Metabolism","volume":"51","author":"Epstein","year":"1997","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3121\/cmr.2015.1282","article-title":"Hypoxia: The Force That Drives Chronic Kidney Disease","volume":"14","author":"Fu","year":"2016","journal-title":"Clin. Med. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Hypoxia Signaling in Human Diseases and Therapeutic Targets","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_35","first-page":"3810","article-title":"Hypoxia Promotes Fibrogenesis in Vivo via HIF-1 Stimulation of Epithelial-to-Mesenchymal Transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1523-1755.2002.00401.x","article-title":"Interleukin-1beta Induces Human Proximal Tubule Cell Injury, Alpha-Smooth Muscle Actin Expression and Fibronectin Production","volume":"62","author":"Vesey","year":"2002","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1096\/fj.201901950R","article-title":"Hypoxia-Induced HE4 in Tubular Epithelial Cells Promotes Extracellular Matrix Accumulation and Renal Fibrosis via NF-\u039aB","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11255-020-02474-2","article-title":"Recent Advances in Understanding the Role of Hypoxia-Inducible Factor 1\u03b1 in Renal Fibrosis","volume":"52","author":"Wei","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular Hyperfiltration: Definitions, Mechanisms and Clinical Implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2014030278","article-title":"A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD","volume":"26","author":"Kriz","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective Tissue Growth Factor Is a Mediator of Angiotensin II-Induced Fibrosis","volume":"108","author":"Lorenzo","year":"2003","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tampe, D., Schridde, L., Korsten, P., Str\u00f6bel, P., Zeisberg, M., Hakroush, S., and Tampe, B. (2021). Different Patterns of Kidney Fibrosis Are Indicative of Injury to Distinct Renal Compartments. Cells, 10.","DOI":"10.3390\/cells10082014"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","article-title":"The Fibrosis-Cell Death Axis in Heart Failure","volume":"21","author":"Piek","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic Lupus Erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on Lupus Nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2215\/CJN.10601016","article-title":"Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis","volume":"12","author":"Rijnink","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/1756-185X.13254","article-title":"Chronicity Index, Especially Glomerular Sclerosis, Is the Most Powerful Predictor of Renal Response Following Immunosuppressive Treatment in Patients with Lupus Nephritis","volume":"21","author":"Park","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/0961203318776109","article-title":"Histological Predictors of Renal Outcome in Lupus Nephritis: The Importance of Tubulointerstitial Lesions and Scoring of Glomerular Lesions","volume":"27","author":"Andronesi","year":"2018","journal-title":"Lupus"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2015.01.008","article-title":"Anti-DsDNA Antibody Induces Soluble Fibronectin Secretion by Proximal Renal Tubular Epithelial Cells and Downstream Increase of TGF-\u03921 and Collagen Synthesis","volume":"58","author":"Yung","year":"2015","journal-title":"J. Autoimmun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.4049\/jimmunol.154.9.4857","article-title":"Murine and Human Antibodies to Native DNA That Cross-React with the A and D SnRNP Polypeptides Cause Direct Injury of Cultured Kidney Cells","volume":"154","author":"Koren","year":"1995","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/jaut.1997.9998","article-title":"Identification of Endothelial Cell Membrane Proteins That Bind Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus by Direct or Indirect Mechanisms","volume":"10","author":"Chan","year":"1997","journal-title":"J. Autoimmun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1177\/0961203311416533","article-title":"Discrepancies in Glomerular and Tubulointerstitial\/Vascular Immune Complex IgG Subclasses in Lupus Nephritis","volume":"20","author":"Satoskar","year":"2011","journal-title":"Lupus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.578952","article-title":"The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis","volume":"11","author":"Hong","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e93009","DOI":"10.1172\/jci.insight.93009","article-title":"Single Cell RNA Sequencing to Dissect the Molecular Heterogeneity in Lupus Nephritis","volume":"2","author":"Der","year":"2017","journal-title":"JCI Insight"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular Cell and Keratinocyte Single-Cell Transcriptomics Applied to Lupus Nephritis Reveal Type I IFN and Fibrosis Relevant Pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/gerona\/61.11.1130","article-title":"TIMP-1 Promotes Age-Related Renal Fibrosis through Upregulating ICAM-1 in Human TIMP-1 Transgenic Mice","volume":"61","author":"Zhang","year":"2006","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1681\/ASN.2009080876","article-title":"Integrative Urinary Peptidomics in Renal Transplantation Identifies Biomarkers for Acute Rejection","volume":"21","author":"Ling","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2021.676082","article-title":"IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-018-1568-1","article-title":"Dysregulated Heme Oxygenase-1Low M2-like Macrophages Augment Lupus Nephritis via Bach1 Induced by Type I Interferons","volume":"20","author":"Kishimoto","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/rheumatology\/keu249","article-title":"Interferon-\u03b1-Induced B-Lymphocyte Stimulator Expression and Mobilization in Healthy and Systemic Lupus Erthymatosus Monocytes","volume":"53","author":"Gordon","year":"2014","journal-title":"Rheumatology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12950-019-0227-x","article-title":"Mesangial Cells Are Key Contributors to the Fibrotic Damage Seen in the Lupus Nephritis Glomerulus","volume":"16","author":"Wright","year":"2019","journal-title":"J. Inflamm."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Sol\u00e9, C., Molin\u00e9, T., Vidal, M., Ordi-ros, J., and Cort\u00e9s-hern\u00e1ndez, J. (2019). An Exosomal Urinary MiRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis. Cells, 8.","DOI":"10.3390\/cells8080773"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11926-021-00984-1","article-title":"A Review of Complement Activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e000576","DOI":"10.1136\/lupus-2021-000576","article-title":"Membrane Attack Complex (MAC) Deposition in Renal Tubules Is Associated with Interstitial Fibrosis and Tubular Atrophy: A Pilot Study","volume":"9","author":"Wang","year":"2022","journal-title":"Lupus Sci. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and Biological Roles of the Dickkopf Family of Wnt Modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/ATVBAHA.119.312612","article-title":"Dkk (Dickkopf) Proteins","volume":"39","author":"Baetta","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Sciascia, S., Barinotti, A., Radin, M., Cecchi, I., Menegatti, E., Terzolo, E., Rossi, D., Baldovino, S., Fenoglio, R., and Roccatello, D. (2022). Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. J. Clin. Med., 11.","DOI":"10.3390\/jcm11112977"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1038\/s41598-018-28611-7","article-title":"Lupus Nephritis Pathology Prediction with Clinical Indices","volume":"8","author":"Tang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.2010.13","article-title":"Tubulointerstitial Lesions of Patients with Lupus Nephritis Classified by the 2003 International Society of Nephrology and Renal Pathology Society System","volume":"77","author":"Yu","year":"2010","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acr.20441","article-title":"Predicting Outcomes of Lupus Nephritis with Tubulointerstitial Inflammation and Scarring","volume":"63","author":"Hsieh","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse Proliferative Lupus Nephritis: Identification of Specific Pathologic Features Affecting Renal Outcome","volume":"25","author":"Austin","year":"1984","journal-title":"Kidney Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ckj\/sfx093","article-title":"Interstitial Inflammation and Interstitial Fibrosis and Tubular Atrophy Predict Renal Survival in Lupus Nephritis","volume":"11","author":"Wilson","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.semarthrit.2017.07.007","article-title":"Tubulointerstitial Damage Predicts End Stage Renal Disease in Lupus Nephritis with Preserved to Moderately Impaired Renal Function: A Retrospective Cohort Study","volume":"47","author":"Broder","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semarthrit.2019.06.002","article-title":"Clinical Characteristics and Renal Prognosis Associated with Interstitial Fibrosis and Tubular Atrophy (IFTA) and Vascular Injury in Lupus Nephritis Biopsies","volume":"49","author":"Leatherwood","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s40620-021-01007-z","article-title":"The Extent of Tubulointerstitial Inflammation Is an Independent Predictor of Renal Survival in Lupus Nephritis","volume":"34","author":"Gomes","year":"2021","journal-title":"J. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.34067\/KID.0005512021","article-title":"Beyond ISN\/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival","volume":"3","author":"Moroni","year":"2022","journal-title":"Kidney360"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","article-title":"Inflammation in Areas of Tubular Atrophy in Kidney Allograft Biopsies: A Potent Predictor of Allograft Failure","volume":"10","author":"Mannon","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (CAPACITY): Two Randomised Trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rmed.2016.02.001","article-title":"Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Combined Evidence from the TOMORROW and INPULSIS(\u00ae) Trials","volume":"113","author":"Richeldi","year":"2016","journal-title":"Respir. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.01050207","article-title":"Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis","volume":"2","author":"Cho","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and Anti-Inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-Fibrotic Effects of Nintedanib in Lung Fibroblasts Derived from Patients with Idiopathic Pulmonary Fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14397595.2019.1696505","article-title":"Nintedanib: New Indication for Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"30","author":"Kuwana","year":"2020","journal-title":"Mod. Rheumatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1042\/CS20170134","article-title":"Nintedanib, a Triple Tyrosine Kinase Inhibitor, Attenuates Renal Fibrosis in Chronic Kidney Disease","volume":"131","author":"Liu","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000517692","article-title":"Nintedanib-Induced Renal Thrombotic Microangiopathy","volume":"11","author":"Fujita","year":"2021","journal-title":"Case Reports Nephrol. Dial."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000509670","article-title":"Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy","volume":"7","author":"Feng","year":"2021","journal-title":"Kidney Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T Cells Produced in Vivo to Treat Cardiac Injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting Cardiac Fibrosis with Engineered T Cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T Cells Reverse Senescence-Associated Pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ekir.2017.03.011","article-title":"A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis","volume":"2","author":"Vincenti","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000513777","article-title":"Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome","volume":"52","author":"Chertow","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Isaka, Y. (2018). Targeting TGF-\u03b2 Signaling in Kidney Fibrosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092532"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-Term Study of Mycophenolate Mofetil as Continuous Induction and Maintenance Treatment for Diffuse Proliferative Lupus Nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","article-title":"Mycophenolate Mofetil Inhibits Rat and Human Mesangial Cell Proliferation by Guanosine Depletion","volume":"14","author":"Hauser","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ndt\/15.2.184","article-title":"Effects of Mycophenolic Acid on Human Renal Proximal and Distal Tubular Cells in Vitro","volume":"15","author":"Baer","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00417-002-0452-4","article-title":"Antiproliferative Effect of Mycophenolate Mofetil on Cultured Human Tenon Fibroblasts","volume":"240","author":"Heinz","year":"2002","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/art.24573","article-title":"Anti-DNA Antibody Induction of Protein Kinase C Phosphorylation and Fibronectin Synthesis in Human and Murine Lupus and the Effect of Mycophenolic Acid","volume":"60","author":"Yung","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2015.1054027","article-title":"Distinct Effects of Mycophenolate Mofetil and Cyclophosphamide on Renal Fibrosis in NZBWF1\/J Mice","volume":"48","author":"Yung","year":"2015","journal-title":"Autoimmunity"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1042\/CS20190536","article-title":"Effect of Mycophenolate and Rapamycin on Renal Fibrosis in Lupus Nephritis","volume":"133","author":"Zhang","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"866077","DOI":"10.3389\/fphar.2022.866077","article-title":"Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/0886022X.2022.2058962","article-title":"Iguratimod Alleviates Tubulo-Interstitial Injury in Mice with Lupus","volume":"44","author":"Xue","year":"2022","journal-title":"Ren. Fail."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/14317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:21:12Z","timestamp":1760145672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/14317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":105,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232214317"],"URL":"https:\/\/doi.org\/10.3390\/ijms232214317","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}